FDA Commissioner Califf's Pharmaceutical Industry Revolving Door Scrutinized

| Importance: 8/10

FDA Commissioner Robert Califf faces ongoing criticism for his extensive pharmaceutical industry ties. Having received over $8 million from drug companies and worked as a consultant for major pharmaceutical firms, Califf pledged to extend post-employment restrictions from 2 to 4 years to mitigate ‘revolving door’ concerns. His connections include consulting roles with Merck, Biogen, Eli Lilly, and a leadership position at Verily Life Sciences (Alphabet).

Key Actors

Robert Califf FDA Verily Life Sciences Joe Manchin Bernie Sanders

Tags

regulatory-capture pharmaceutical-industry fda corporate-influence government-ethics

Sources (3)

Help Improve This Timeline

Found an error or have additional information? You can help improve this event.

✏️ Edit This Event ➕ Suggest New Event

Edit: Opens GitHub editor to submit corrections or improvements via pull request.
Suggest: Opens a GitHub issue to propose a new event for the timeline.